Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.069 | 0.2 |